Analysis of the Bethesda System for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes

Advances in Anatomic Pathology

Volumn 19, Issue 5, 2012, Pages 313-319

  Wong, Lawrence Q ^a,b   Baloch, Zubair W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

fine needle aspiration cytology; the Bethesda System for Reporting Thyroid Cytopathology; thyroid cytology; thyroid nodule

Indexed keywords

ASPIRATION BIOPSY; BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY; BIOPSY TECHNIQUE; CANCER DIAGNOSIS; CYTOPATHOLOGY; FOLLICULAR CARCINOMA; FOLLOW UP; HUMAN; NOMENCLATURE; ONCOCYTOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; FEMALE; HUMANS; MALE; PRECANCEROUS CONDITIONS; TERMINOLOGY AS TOPIC; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY;

EID: 84865488195     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3182666398     Document Type: Review

References (48)

1. Bomeli SR, LeBeau SO, Ferris RL. Evaluation of a thyroid nodule. Otolaryngol Clin North Am. 2010;43:229-238. vii.
2. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126:226-231. (Pubitemid 27061578)
3. Mandel SJA. 64-year-old woman with a thyroid nodule. JAMA. 2004;292:2632-2642.
4. ADAM Medical EncyclopediaThyroid nodule. April 19, 2010. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004524. Accessed April 4, 2012.
5. Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract. 2010;16:468-475.
6. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008. November 2011. Available at: http://seer.cancer.gov/statfacts/html/ thyro.html. Accessed April 4, 2012.
7. Wong CK, Wheeler MH. Thyroid nodules: rational management. World J Surg. 2000;24:934-941. (Pubitemid 30461214)
8. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1986;61:978-996. (Pubitemid 17205209)
9. Tandon S, Shahab R, Benton JI, et al. Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis. Head Neck. 2008;30:1246-1252.
10. Rabaglia JL, Kabbani W, Wallace L, et al. Effect of the Bethesda System for Reporting Thyroid Cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery. 2010;148:1267-1272; discussion 1272-3.
11. Schinstine M. A brief description of the Bethesda System for reporting thyroid fine needle aspirates. Hawaii Med J. 2010;69:176-178.
12. Cibas ES, Ali SZ. Conference NTFSotS. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132:658-665.
13. Lew JI, Snyder RA, Sanchez YM, et al. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg. 2011;213:188-194; discussion 194-195.
14. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer. 2009;117:195-202.
15. Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111:306-315.
16. Piana S, Frasoldati A, Ferrari M, et al. Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18, 000 FNAs reported at the same institution during 1998-2007. Cytopathology. 2011;22:164-173.
17. Rorive S, D'Haene N, Fossion C, et al. Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. Eur J Endocrinol. 2010;162:1107-1115.
18. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007;111:508-516. (Pubitemid 350304903)
19. Crowe A, Linder A, Hameed O, et al. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions. Cancer Cytopathol. 2011;119:315-321.
20. Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009;19:1215-1223.
21. Wu HH, Rose C, Elsheikh TM. The Bethesda System for Reporting Thyroid Cytopathology: an experience of 1, 382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol. 2012;40:399-403.
22. Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fineneedle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2010;134:450-456.
23. Renshaw AA. Should "atypical follicular cells" in thyroid fineneedle aspirates be subclassified? Cancer Cytopathol. 2010;118:186-189.
24. Bohacek L, Milas M, Mitchell J, et al. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules. Ann Surg Oncol. 2012;19:45-51.
25. Kim SK, Hwang TS, Yoo YB, et al. Surgical results of thyroid nodules according to a management guideline based on the BRAF (V600E) mutation status. J Clin Endocrinol Metab. 2011;96:658-664.
26. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics. 2000;56:345-351. (Pubitemid 30422620)
27. Yu Q, Tang W, Ma Y, et al. Comparing multiple sensitivities and specificities with different diagnostic criteria: applications to sexual abuse and sexual health research. Comput Stat Data Anal. 2008;53:27-37.
28. Tee YY, Lowe AJ, Brand CA, et al. Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg. 2007;246:714-720. (Pubitemid 350035645)
29. Raab SS, Vrbin CM, Grzybicki DM, et al. Errors in thyroid gland fine-needle aspiration. Am J Clin Pathol. 2006;125:873-882. (Pubitemid 43801538)
30. Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
31. Yoder BJ, Redman R, Massoll NA. Validation of a five-tier cytodiagnostic system for thyroid fine needle aspiration biopsies using cytohistologic correlation. Thyroid. 2006;16:781-786. (Pubitemid 44757117)
32. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11, 000 biopsies. Clin Lab Med. 1993;13:699-709. (Pubitemid 23267635)
33. Bose S, Walts AE. Thyroid fine needle aspirate: a postbethesda update. Adv Anat Pathol. 2012;19:160-169.
34. Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and costeffectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5, 688 cases. Diagn Cytopathol. 2002;27:1-4. (Pubitemid 34721605)
35. Zhu W, Michael CW. How important is on-site adequacy assessment for thyroid FNA? An evaluation of 883 cases. Diagn Cytopathol. 2007;35:183-186. (Pubitemid 46355354)
36. Marchevsky AM, Walts AE, Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fineneedle aspiration biopsies. Diagn Cytopathol. 2010;38:252-259.
37. Marhefka GD, McDivitt JD, Shakir KM, et al. Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: does the result, benign vs. suspicious for a malignant process, in these nodules make a difference? Acta Cytol. 2009;53:517-523.
38. Singh RS, Wang HH. Eliminating the "atypia of undetermined significance/follicular lesion of undetermined significance" category from the bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2011;136:896-902.
39. Walts AE, Bose S, Fan X, et al. A simplified Bethesda System for Reporting Thyroid Cytopathology using only four categories improves intra-and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks. Diagn Cytopathol. 2012;40(Suppl 1):E62-E68.
40. Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer. 2009;117:298-304.
41. Bongiovanni M, Crippa S, Baloch Z, et al. Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol. 2012;120:117-125.
42. Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy. Cancer Cytopathol. 2011;119:322-327.
43. Abele JS, Levine RA. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol. 2010;118:415-422.
44. VanderLaan PA, Marqusee E, Krane JF. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol. 2011;136:572-577.
45. Lubitz CC, Faquin WC, Yang J, et al. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 2010;20:25-31.
46. Jing X, Roh MH, Knoepp SM, et al. Minimizing the diagnosis of "follicular lesion of undetermined significance" and identifying predictive features for neoplasia. Diagn Cytopathol. 2011;39:737-742.
47. VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach? Am J Clin Pathol. 2011;135:770-775.
48. Tetikkurt US, Oz Puyan F, Oz F, et al. Diagnostic value of liquid-based (Liqui-PREP) preparations and interobserver reproducibility in fine needle aspiration cytology of the nodular thyroid lesions. Diagn Cytopathol. 2012;40:388-393.